Prom and pprom
Reading File
Finding Sources
Searching PubMed
"premature rupture of membranes" management
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
I now have all the content needed to write a comprehensive answer on PROM and PPROM.
PROM and PPROM: Comprehensive Clinical Overview
Definitions
PROM (Premature Rupture of Membranes) - rupture of the fetal membranes before the onset of labor, at or beyond 37 weeks' gestation.
PPROM (Preterm Premature Rupture of Membranes) - rupture of the fetal membranes before 37 weeks' gestation, prior to the onset of labor. This is the clinically more challenging entity and carries significant fetal and maternal risk.
Latent period - the interval from membrane rupture to the onset of labor. Shorter at term; can be days to weeks in PPROM.
Incidence
- PROM at term complicates ~8-10% of pregnancies
- PPROM occurs in ~3% of pregnancies but accounts for ~30-40% of all preterm births
- PPROM before 32 weeks accounts for the highest morbidity burden
Pathophysiology of Membrane Rupture
The fetal membranes consist of two layers:
- Amnion - single cuboidal epithelial layer with compact and spongy connective tissue layers
- Chorion - thicker, with reticular and trophoblastic layers; adheres to maternal decidua
The amnion and chorion fuse by end of 14th week. Together they are stronger than either layer alone.
With advancing gestation, physiologic membrane remodeling occurs due to changes in collagen content/type, intercellular matrix changes, and progressive cellular apoptosis. Structural weakening is most pronounced near the internal cervical os - the typical site of rupture.
Key biochemical mediators:
- Matrix metalloproteinases (MMPs) - degrade collagen
- Tissue inhibitors of MMPs (TIMPs) - decreased levels accelerate weakening
- Thrombin - stimulates MMP release
- Increased poly(ADP-ribose) polymerase cleavage
- Uterine contractions increase intraamniotic pressure, physically stressing membranes
In PPROM specifically, ascending bacteria secrete collagenases and proteases directly weakening membranes. Amniotic fluid cultures after PPROM are positive in 25-35% of cases. Pathogens associated with PPROM include:
- Neisseria gonorrhoeae
- Chlamydia trachomatis
- Trichomonas vaginalis
- Group B beta-hemolytic Streptococcus (GBS)
- Bacterial vaginosis organisms
(Creasy & Resnik's Maternal-Fetal Medicine, p. 920)
Risk Factors
| Category | Specific Factors |
|---|---|
| Infectious | UTIs, STIs, bacterial vaginosis, GBS colonization |
| Structural | Short cervix (<25 mm), prior cerclage, prior cervical conization |
| Obstetric history | Prior preterm birth/PPROM (3.3x increased risk), prior preterm labor |
| Anatomic/uterine | Polyhydramnios, multiple gestation, uterine overdistension |
| Maternal | Low BMI (<19.8 kg/m²), low socioeconomic status, nutritional deficiencies (copper, ascorbic acid), smoking |
| Bleeding | 2nd/3rd trimester bleeding, placental abruption |
| Connective tissue | Ehlers-Danlos syndrome |
| Pulmonary | Acute pulmonary disease |
The strongest single risk factor is a prior preterm birth due to PPROM - conferring a 3.3-fold increased risk for recurrence and a 13.5-fold higher risk for subsequent delivery before 28 weeks.
Diagnosis
Avoid digital cervical examination - it shortens the latent period and increases infection risk. Always use sterile speculum examination instead.
Clinical Triad - Diagnoses 90% of cases:
| Test | Method | Interpretation | Caveats |
|---|---|---|---|
| History | Gush + continued fluid leakage | High suspicion | Ask patient to Valsalva with speculum in place |
| Nitrazine paper | pH testing of vaginal fluid | Blue = pH >6.5 = amniotic fluid | False positives: blood, semen, BV, trichomoniasis, soap, antiseptics. False negative rate ~7% |
| Ferning test | Swab posterior fornix; dry on glass slide | Crystalline arborization pattern | False positives: cervical mucus. Obscured by blood |
Ferning of amniotic fluid - the classic branching "fern-like" crystalline pattern seen on microscopy (Tintinalli's Emergency Medicine)
Additional Investigations:
- Ultrasound - assess amniotic fluid volume (not diagnostic alone). AFI <5 cm predicts impending delivery
- Amniocentesis - Gram stain, culture, glucose, leukocyte esterase for suspected intraamniotic infection
- Cervicovaginal fetal fibronectin - useful for risk stratification in women with prior preterm birth + short cervix
- Newer biomarkers - placental alpha-microglobulin-1 (PAMG-1) and insulin-like growth factor binding protein-1 (IGFBP-1) assays (AmniSure, Actim PROM) - high sensitivity/specificity, useful when clinical exam equivocal
(Tintinalli's Emergency Medicine, p. 1769-1785)
Complications
Fetal/Neonatal:
- Prematurity (primary driver of morbidity)
- Respiratory distress syndrome (RDS)
- Intraventricular hemorrhage (IVH)
- Necrotizing enterocolitis (NEC)
- Neonatal sepsis
- Umbilical cord prolapse/compression - risk of fetal death
- Pulmonary hypoplasia (especially with PPROM <23 weeks when lung development requires amniotic fluid)
- Limb contractures (oligohydramnios sequence)
- Fetal death
Maternal:
- Chorioamnionitis (intrauterine infection) - most common complication; risk increases with duration of rupture
- Placental abruption
- Postpartum endometritis
- Retained placenta
- Sepsis
The "Periviable" window (<23 weeks):
PPROM before 23 weeks carries the gravest prognosis. Survival rates are low, pulmonary hypoplasia is common due to oligohydramnios during critical lung development, and limb deformities from positional compression occur. A 2024 systematic review (PMID 38593987) quantified the substantial maternal and neonatal risks in periviable PPROM.
Management
Management depends critically on gestational age and clinical status. There is no single algorithm applicable to all circumstances.
Indications for IMMEDIATE delivery (regardless of gestational age):
- Chorioamnionitis
- Placental abruption
- Non-reassuring fetal heart rate tracings
- Advanced labor
PROM at Term (≥37 weeks)
- Deliver - induction of labor is appropriate; expectant management for up to 12-24 hours is an option but increases infection risk
- GBS prophylaxis per culture status
- No tocolysis indicated
PPROM at 34-36+6 Weeks
- Deliver - risk of prematurity complications is low; risk of chorioamnionitis from prolonged rupture outweighs benefit of expectant management
- GBS prophylaxis, betamethasone if not previously given
PPROM at 32-33+6 Weeks
- Expectant management (conservative management) is generally favored
- Corticosteroids (betamethasone)
- GBS prophylaxis/antibiotics
- Monitor closely for chorioamnionitis
PPROM at 23-31+6 Weeks - Core Management Bundle
1. Corticosteroids
- Betamethasone 12 mg IM x2 doses 24 hours apart - reduces RDS, IVH, NEC, and overall neonatal mortality
- A single rescue course may be considered if >2 weeks since initial course and delivery anticipated within 7 days
2. Antibiotics (latency prolongation)
- Standard regimen: Ampicillin + Erythromycin x 7 days (ORACLE trial regimen)
- Reduces risk of chorioamnionitis and prolongs latency period
- Avoid amoxicillin-clavulanate (Augmentin) - associated with increased NEC risk
- GBS prophylaxis per vaginal-rectal culture results
3. Magnesium sulfate for neuroprotection
- Given when delivery anticipated at <32 weeks
- Reduces risk of cerebral palsy
4. Tocolysis
- Generally NOT recommended for PPROM - may mask signs of chorioamnionitis
- Short-term tocolysis may be considered only to allow corticosteroid completion in select cases
5. Monitoring during expectant management
- Daily or twice-daily fetal heart rate monitoring
- Serial ultrasound for amniotic fluid, fetal growth, biophysical profile
- Regular maternal vital signs (fever, tachycardia), WBC, uterine tenderness
- Pelvic rest (no intercourse, no digital exams)
- Hospitalization - debated; outpatient management may be considered in stable, compliant patients at later gestational ages
PPROM Before 23 Weeks (Periviable)
- Counseling about poor prognosis is essential
- Options include: expectant management, induction of labor, or comfort care
- If expectant management pursued: same infection/surveillance monitoring
- Survival rates are low; pulmonary hypoplasia risk is high
- Amnioinfusion (experimental) has been studied to reduce oligohydramnios-related complications
(Creasy & Resnik's Maternal-Fetal Medicine, pp. 920-930; Morgan & Mikhail's Clinical Anesthesiology 7e)
Anesthetic Considerations (PPROM + Chorioamnionitis)
From Morgan & Mikhail's Clinical Anesthesiology:
- Chorioamnionitis carries risk of maternal sepsis - careful hemodynamic assessment before neuraxial anesthesia
- Epidural/spinal generally safe even with low-grade chorioamnionitis in absence of frank sepsis or coagulopathy
- Risk of systemic infection spread with neuraxial block is theoretical but not well-documented in clinical practice
- Neonatal team should be present at delivery given high risk of neonatal compromise
Key Summary Comparison
| Feature | PROM | PPROM |
|---|---|---|
| Gestational age | ≥37 weeks | <37 weeks |
| Common cause | Physiologic weakening | Infection, inflammation, short cervix |
| Main risk | Chorioamnionitis if prolonged | Prematurity + chorioamnionitis + cord prolapse |
| Management | Deliver (induction) | Expectant management + steroids + antibiotics |
| Tocolysis | No | Generally no (exception: buy time for steroids) |
| Steroids | Not indicated | Yes (23-34 weeks) |
| MgSO₄ neuroprotection | No | Yes (<32 weeks) |
Sources:
- Creasy & Resnik's Maternal-Fetal Medicine: Principles and Practice, pp. 920-930
- Tintinalli's Emergency Medicine: A Comprehensive Study, pp. 1769-1798
- Morgan & Mikhail's Clinical Anesthesiology, 7e
- Recent evidence: Periviable PPROM systematic review - Saucedo et al., Am J Perinatol 2024 (PMID 38593987)
This is a shared conversation. Sign in to Orris to start your own chat.